IACP Responds to FDA's Makena(R) 17-P Update

IACP has responded to the FDA's Makena(R) 17-P update issued last week by stating FDA Study Affirms no Major Safety Issues with Compounded 17-P. To read an article about IACP statement click here.  To read additional articles click here, here and here.